NCT04435769View on ClinicalTrials.gov

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Atrial Fibrillation
Trial Locations (1)

150 06

Fakultní nemocnice Motol, Prague

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04435769 - Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment | Biotech Hunter | Biotech Hunter